tbuckley/cabot-search huggingface dataset:
Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma
Authors: Bruno Paiva, Martin Perez-Andres, María-Belén Vidriales, Julia Almeida, Natalia de las Heras, María-Victoria Mateos, Lucía López-Corral, Norma C. Gutierrez, Juan Blanco, Albert Oriol, Miguel T. Hernandez, Felipe de Arriba, Alfonso Garcia de Coca, María José Terol, Javier De La Rubia, Yolanda Gonzalez, Alejandro Martín, Anna Sureda, Martin Schmidt-Hieber, Alexander Schmitz, Hans E Johnsen, Juan-Jose Lahuerta, Joan Blade, Jesus F San Miguel, Alberto Orfao
Journal: Blood (2010)
Codanin-1, the Product of the Gene Mutated In Congenital Dyserythropoietic Anemia Type I (CDA I), Binds to Histone Chaperone Asf1a and Inhibits Its Nucleosome Assembly Activity
Authors: Hannah Tamary, Nathaly Marcoux, Sharon Noy-Lotan, Isaac Yaniv, Orly Dgany
Journal: Blood (2010)
National Trends in American Heart Association Revised Life's Simple 7 Metrics Associated With Risk of Mortality Among US Adults
Authors: Liyuan Han, Dingyun You, Wenjie Ma, Thomas Astell-Burt, Xiaoqi Feng, Shiwei Duan, Lu Qi
Journal: JAMA Network Open (2019)

The American Heart Association (AHA) introduced the Life's Simple 7 (LS7) metrics to assess and promote cardiovascular health. However, several shortcomings of these metrics have been identified. Therefore, a revised set of LS7 metrics was developed.To evaluate national trends in the metrics addressed by the revised LS7 and the individual and combined associations of the revised LS7 metrics with all-cause and cause-specific mortality and to compare these measures with the AHA recommended LS7 metrics.This national cross-sectional study used data from the National Health and Nutrition Examination Survey from 1988 to 2016. The revised LS7 metrics included a combination of the body mass index and waist to hip ratio, Healthy Eating Index-2010, and a lower blood pressure threshold of greater than or equal to 130/80 mm Hg in addition to physical activity, smoking, total cholesterol, and fasting blood glucose. Data for this study were analyzed from June 1, 2017, to December 31, 2017.The primary outcome was all-cause mortality. The secondary outcome was cancer and cardiovascular disease (CVD) mortality.Data were available for 13 606 adults in 1988 to 1994 (7329 [53%] female; mean [SD] age, 47 [17.7] years), 6360 in 1999 to 2004 (3442 [54%] female; mean [SD] age, 47 [18.6] years), 10 618 in 2005 to 2010 (5428 [51%] female; mean [SD] age, 47 [17.5] years), and 10 773 in 2011 to 2016 (5474 [50%] female; mean [SD] age, 48 [17.4] years). Compared with a revised LS7 score of 0 to 1, the adjusted hazard ratios for a revised LS7 score of 5 to 7 were 0.46 (95% CI, 0.35-0.61) for all-cause mortality, 0.42 (95% CI, 0.25-0.68) for cancer mortality, and 0.37 (95% CI, 0.24-0.55) for CVD mortality, respectively. The adjusted hazard ratios for participants who met 6 or more AHA recommended ideal LS7 metrics were 0.49 (95% CI, 0.33-0.74) for all-cause mortality, 0.60 (95% CI, 0.29-1.25) for cancer mortality, and 0.24 (95% CI, 0.13-0.47) for CVD mortality. Participants with a body mass index of 29.9 or less but without central obesity were independently associated with lower risk of all-cause and CVD mortality. Blood pressure was associated with 36.7% or more of the observed population-attributable fraction of mortality.The individual revised LS7 metrics with modified criteria regarding weight, blood pressure, and diet provide more information about factors associated with cancer mortality than the original AHA LS7 metrics.
An innate-like Vδ1 <sup>+</sup> γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
Authors: Yin Wu, Fernanda Kyle-Cezar, Richard T. Woolf, Cristina Naceur-Lombardelli, Julie Owen, Dhruva Biswas, Anna Lorenc, Pierre Vantourout, Patrycja Gazinska, Anita Grigoriadis, Andrew Tutt, Adrian Hayday
Journal: Science Translational Medicine (2019)

An innate-like γδ T cell compartment in healthy human breast is described and shown to correlate with remission in triple-negative breast cancer.
Generation of Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ Th1 Helper T Cells by Transfer of T-Cell Receptor Genes Isolated from a WT1-Specific CD8+ Cytotoxic T-Lymphocyte Clone.
Authors: Masaki Yasukawa, Hironari Niiya, Taichi Azuma, Naoyuki Uchida, Yoshihiro Yakushijin, Ikuya Sakai, Takaaki Hato, Shigeru Fujita, Takemasa Tsuji, Takashi Nishimura
Journal: Blood (2004)
G to C Transition At Position −173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)
Authors: Damià Romero, Beatriz Martin-Antonio, Marta Pratcorona, Pablo Trujillo, Ildefonso Espigado, David Gallardo, Anna Bosch, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenz-Velasco, Rafael De La Camara, Salut Brunet, Jose B Nieto, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Jordi Esteve, Alvaro Urbano-Ispizua
Journal: Blood (2011)
Chemical Derivatives of the Anti-Leukemia Stem Cell Compound 4-Benzyl-2-Methyl-1,2,4-Thiadiazolidine-3,5-Dione (TDZD-8) with Improved Activity.
Authors: Monica L. Guzman, Shama Nasim, Marlene Balys, Cheryl A Corbett, Peter A Crooks, Craig T. Jordan
Journal: Blood (2009)
Low-Dose Hypomethylating Agents (HMAs) Are Effective in Patients (Pts) with Low- or Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Report on Behalf of the MDS Clinical Research Consortium
Authors: Nicholas J. Short, Guillermo Garcia-Manero, Guillermo Montalban Bravo, Koji Sasaki, Mikkael A. Sekeres, Rami S. Komrokji, David P. Steensma, Amy E. DeZern, Gail J Roboz, Tapan Kadia, Gautam Borthakur, Courtney DiNardo, Darla Miller, Zeev Estrov, Naveen Pemmaraju, Naval Daver, Srdan Verstovsek, Hagop M. Kantarjian, Elias Jabbour
Journal: Blood (2015)
Combining Decitabine With Plerixafor Yields a High Response Rate In Newly Diagnosed Older Patients With AML
Authors: Gail J. Roboz, Joseph M. Scandura, Ellen Ritchie, Yulia Dault, Linda Lam, Wen Xie, Hsiao-Ting Hsu, Danielle Marshall, Paul J Christos, Cindy Ippoliti, Eric J. Feldman, Monica L. Guzman
Journal: Blood (2013)
Overexpression of Ribosomal Proteins Is Associated with Resistance to Immunochemotherapy in Diffuse Large B-Cell Lymphoma Patients
Authors: Martin Stenson, Susanne Bram-Ednersson, Herman Nilsson-Ehle, Mimmie Stern, Gunilla Enblad, Sverker Hasselblom, Per-Ola Andersson
Journal: Blood (2016)
Plasma Vincristine Levels Are 100-Fold Higher with Marqibo® (Vincristine Sulfate LIPOSOME Injection) in Place of Standard Vincristine in Combination Chemotherapy of Patients ≥ 60 Years Old with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Authors: Eunice S. Wang, Gary J Schiller, Leonard T. Heffner, Wendy Stock, Arati V. Rao, Gail J. Roboz, Peter Westervelt, Matthew J. Wieduwilt, Jay Yang, Lucy Prasad, Karen Segarini, Stuart L. Goldberg
Journal: Blood (2015)
Induction Therapy by Ara-C Plus Daunorubicin Versus Ara-C Plus Gemtuzumab Ozogamicin: Interim Analysis of a Randomized Phase II Trial of the SAL In Elderly Patients with Acute Myeloid Leukemia
Authors: Uta Brunnberg, Michael Mohr, Richard Noppeney, Heinz A. Duerk, Maria Cristina Sauerland, Carsten Müller-Tidow, Utz O Krug, Steffen Koschmieder, Torsten Kessler, Rolf M. Mesters, Christiane Schulz, Thomas Buchner, Gerhard Ehninger, Ulrich Dührsen, Hubert Serve, Wolfgang E. Berdel
Journal: Blood (2010)
Proline-Rich Tyrosine Kinase-2 (PYK2): A New Target for the Treatment of Hematopoietic Neoplasms with TEL-FGFR3 Fusion or FGFR3 Active Mutation.
Authors: Daisuke Okamura, Fumiharu Yagasaki, Tomoya Maeda, Maho Ishikawa, Itsuro Jinnai, Masami Bessho
Journal: Blood (2007)
Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study
Authors: Christophe Hézode, Michael W. Fried, Massimo Colombo, Marc Bourlière, Ulrich Spengler, Ziv Ben-Ari, Simone I. Strasser, Ponni Perumalswami, Philippe Zamor, William M. Lee, Rohit Satoskar, Ioannis Koskinas, Graham Foster, Kenneth E. Sherman, Satawat Thongsawat, Tawesak Tanwandee, Leslie Morgan, Jingjun Qiu, Peggy Hwang, Michael Robertson, Bach-Yen Nguyen, Eliav Barr, Janice Wahl, Barbara Haber, Robert Chase, Rohit Talwani, Vito Di Marco
Journal: Blood (2016)
Autoreactive T Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Specifically Recognize Glycosyl- Phosphatidyl-Inositol (GPI)
Authors: Lucia Gargiulo, Michela Sica, Maria Papaioannou, Giulia Talini, Aristeidis Chaidos, Barbara Richichi, Andrei V Nikolaev, Cristina Nativi, Mark Layton, Josu de la Fuente, Irene Roberts, Lucio Luzzatto, Rosario Notaro, Anastasios Karadimitris
Journal: Blood (2012)
Next steps for the BMA: will new leadership deliver much needed change?
Authors: Abi Rimmer
Journal: BMJ (2019)

<b>Chaand Nagpaul</b>, BMA council chair, and <b>Tom Grinyer</b>, who joined the organisation as chief executive in July, tell <b>Abi Rimmer</b> how new changes will lead to a more democratic organisation and tackle inequalities
UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL
Authors: Sandra Christoph, Deborah DeRyckere, Susan Sather, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Amy van Deusen, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, Gary L. Johnson, Douglas K. Graham
Journal: Blood (2011)
Radiation-Induced Meningiomas: A perspective from the West of Scotland
Authors: Mari Roberts, Andrew McIlwraith, Kevin Owusu-Agyemang, Alhafidz Hamdan, Charles Champeaux, Deborah Houston, Athanasios Grivas
Journal: Neuro-Oncology (2019)

Abstract Introduction Meningioma is the most common intracranial neoplasm to be induced by ionising radiation. Patients receiving childhood radiotherapy do not have routine surveillance to assess for this delayed complication. We aimed to examine our 30 year cohort of surgically treated meningioma in Glasgow. Method We retrospectively reviewed all patients who underwent surgery for meningioma and identified those who previously had childhood cranial irradiation. We then studied their demographics including gender and age at index cranial irradiation, latency period, histological grade and outcome. Results In total there were 982 patients with meningioma (WHO Grade 1 – 69%, Grade 2- 26%, and Grade 3- 1%). Of these, 22 patients had a radiation-induced meningioma. Eleven (50%) of these were WHO Grade 1. Median age at diagnosis of meningioma was 38 years old. Most cases were females (15; 68%, and most common indication for childhood irradiation was leukaemia (11; 50%), followed by pineal region tumours (4; 18%). Mean latency from irradiation to meningioma diagnosis was 25 years. Seven (32%) patients had multiple meningiomata; 5 (71.4%) of these had &gt;2 lesions. Eight patients (36%) had recurrent meningiomata. Conclusion Patients receiving cranial radiation should be enrolled into a surveillance program guided by the reported latency period. A local registry of such patients would provide more information on protective and prognostic factors.
Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study
Authors: Elizabeth C Oelsner, Pallavi P Balte, Surya P Bhatt, Patricia A Cassano, David Couper, Aaron R Folsom, Neal D Freedman, David R Jacobs, Ravi Kalhan, Amanda R Mathew, Richard A Kronmal, Laura R Loehr, Stephanie J London, Anne B Newman, George T O'Connor, Joseph E Schwartz, Lewis J Smith, Wendy B White, Sachin Yende
Journal: The Lancet Respiratory Medicine (2019)
Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients
Authors: Sufia N. Amini, Annemieke Sobels, Christianne Duchateau, Masja De Haas, Leendert Porcelijn, Roger Schutgens, Jaap Jan Zwaginga, Martin R. Schipperus
Journal: Blood (2017)
MicroRNA-9 methylation reflect epigenetic drift and identify patients with risk for C-associated colorectal neoplasia
Authors: Yoshinaga Okugawa, Yuiji Toiyama, Akira Yamamoto, Yusuke Omura, Kurando Kusunoki, Yukina Kusunoki, Takashi Iwata, Hiroyuki Fujikawa, Hiromi Yasuda, Yoshiki Okita, Takeshi Yokoe, Junichiro Hiro, Toshimitsu Araki, Masato Kusunoki
Journal: Annals of Oncology (2019)
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
Authors: Kuniaki Takahashi, Patrick W Serruys, Ply Chichareon, Chun Chin Chang, Mariusz Tomaniak, Rodrigo Modolo, Norihiro Kogame, Michael Magro, Saqib Chowdhary, Ingo Eitel, Robert Zweiker, Paul Ong, Michael Mundt Ottesen, Jan G P Tijssen, Joanna J Wykrzykowska, Robbert J de Winter, Scot Garg, Hans-Peter Stoll, Christian Hamm, Philippe Gabriel Steg, Yoshinobu Onuma, Marco Valgimigli, Pascal Vranckx, Didier Carrie, Stephan Windecker
Journal: Journal of the American College of Cardiology (2019)
Improved Survival in Recent Years of Chronic Myeloid Leukemia (CML) Observed in the Real World in a Cohort of Patients Cared in a Haematological Regional Network HEMATOLIM.
Authors: Pascal Turlure, Nathalie Gachard, Marie-Pierre Gourin, Stéphane Girault, Mohamed Touati, Liliane Remenieras, Stephane Moreau, Celine Philippon, Sophie Lefort, Jean Feuillard, Dominique Bordessoule
Journal: Blood (2009)
Mutation Analysis in 276 Cases of Newly Diagnosed Acute Myeloid Leukemia By Next Generation Sequencing: Association with Established Prognostic Variables and MRC Risk Groups
Authors: Parsa Hodjat, Kankana Ghosh, Priyanka Priyanka, Beenu Thakral, Keyur P. Patel, Mark Routbort, Rashmi Kanagal-Shamana, C. Cameron Yin, Zhuang Zuo, Raja Luthra, Tariq Muzzafar
Journal: Blood (2015)
CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format
Authors: Yumin CUI, Zhihua Huang, Xinfeng Zhang, Wuzhong Shen, Hanyang Chen, Zaiqing Wen, Bo Qi, Lan Luo, Ying Tan, Yun Wu, Ada Kung, Xiaoqiang Yan
Journal: Blood (2018)
Pathogenesis of Ponatinib Associated Vascular Disease in Chronic Myeloid Leukemia: An in Vitro Study
Authors: Ayala Gover-Proaktor, Oren Pasvolsky, Pia Raanani, Arnon Nagler, Saar Shapira, Ido Lubin, Galit Granot, Avi Leader
Journal: Blood (2015)
Somatic Mutations in Commonly Mutated Genes in Myeloid Malignancies May Preexist or Arise in the Course of Chronic Myeloid Leukemia - Different Scenarios of Progression Revealed By Targeted Next-Generation Sequencing
Authors: Marcin M Machnicki, Iwona Solarska, Rafal Ploski, Ilona Seferynska, Tomasz Stoklosa
Journal: Blood (2015)
Decitabine Induces Responses in Patients with Myelodysplastic Syndrome (MDS) after Failure of Azacitidine Therapy.
Authors: Gautam Borthakur, Farhad Ravandi-Kashani, Jorge Cortes, Elias Jabbour, Stefan Faderl, Susan O’Brien, Srdan Verstovsek, Guillermo Garcia-Manero, Beth Ann Newman, Francis Giles, Jean-Pierre Issa, Hagop M. Kantarjian
Journal: Blood (2006)
Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) vs sorafenib in patients with advanced HCC
Authors: Thomas Yau, Gin Wai Kwok, Vikki Tang, Roland Leung, Ann-Shing Lee, Ada Law, Joanne Chiu, Bryan Li, Tan-To Cheung
Journal: Annals of Oncology (2019)
Thalidomide-Dexamethasone vs. Melphalan-Prednisone as First Line Treatment and Thalidomide-Interferon vs. Interferon Maintenance Therapy in Elderly Patients with Multiple Myeloma.
Authors: Heinz Ludwig, Elena Tothova, Roman Hajek, Johannes Drach, Zdenek Adam, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Ingrid Kuhn, Axel Hinke
Journal: Blood (2007)
Allogeneic Stem Cell Transplantation Versus Medical Therapy in Patients with Advanced Myelofibrosis: Matched Survival Analysis and the Effect of JAK2 Inhibitor Therapy
Authors: Lucia Masarova, Uday R. Popat, Prithviraj Bose, Richard E. Champlin, Jorge E. Cortes, Hagop M. Kantarjian, Srdan Verstovsek
Journal: Blood (2016)
Issues in the Adoption of Robotic Surgery
Authors: Myriam J. Curet
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Study of High Dose Lenalidomide Induction and Low Dose Lenalidomide Maintenance for Patients with Hypomethylating Agent Refractory MDS
Authors: Mathew A. Cherian, Raoul Tibes, Theresa Fletcher, Mark A. Fiala, Geoffrey L. Uy, Peter Westervelt, Keith E. Stockerl-Goldstein, Meagan Jacoby, Amanda F. Cashen, John F. DiPersio, Ravi Vij
Journal: Blood (2014)
Immune checkpoint inhibitors: use them early, combined and instead of TACE?
Authors: Enrico N De Toni
Journal: Gut (2019)

We read with interest the recent Gut roundtable paper by Gerbes et al . As highlighted by these authors, treatment of HCC has rapidly changed1: currently, four tyrosine kinase inhibitors, ramucirumab and two immune checkpoint inhibitors (ICP) are approved in different lines of treatment.2 3 Survival of patients with advanced disease have improved correspondingly, and more progress is expected from the burgeoning of trials of ICP-based combination treatment schemas (figure 1).



Figure 1 
Schematic representation of the development in the treatment of advanced-stage HCC based on median overall survival (mOS) data from some recent trials. The arrows are proportional to the reported (grey) or hypothetical (blue) mOS indicated by the respective numbers. The green overlapping arrows represent respectively the real-world and the expected survival (ie, based on the selection of ‘ideal’ candidates for TACE) in BCLC-B patients. The list of trials is not exhaustive and, due to the heterogeneity of patients’ population, not suitable for direct cross-comparison between the trials. Atezo/Bev: combined atezolizumab and bevacizumab; pH, phase of clinical study; TACE, trans-arterial chemoembolisation.



Due to the increasing efficacy of pharmacological treatment, many physicians are inclined to initiate systemic therapy, rather than trans-arterial chemoembolisation …
Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).
Authors: Sanjay R. Mohan, Paul Elson, Cristina Rodriguez, Rachid Baz, Matt Kalaycio, Ronald Sobecks, Anjali Advani, Ed Copelan, Lukasz P. Gondek, Jaroslaw P. Maciejewski, Mikkael A. Sekeres
Journal: Blood (2008)
Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies
Authors: Marco Ruella, David M. Barrett, Saad S Kenderian, Olga Shestova, Ted J. Hofmann, John Scholler, Simon F. Lacey, J. Joseph Melenhorst, Farzana Nazimuddin, Jessica Perazzelli, David A Christian, Christopher A Hunter, David L Porter, Carl H. June, Stephan A. Grupp, Saar I Gill
Journal: Blood (2015)
A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II)
Authors: Sam Schulman, Ajay K Kakkar, Sebastian M Schellong, Samuel Z. Goldhaber, Eriksson Henry, Patrick Mismetti, Anita Vedel Christiansen, Janet Schnee, Clive Kearon
Journal: Blood (2011)
CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.
Authors: Anita K Gandhi, Derek Mendy, Anastasia Parton, Lei Wu, Jolanta Kosek, Ling-Hua Zhang, Lori Capone, Antonia Lopez-Girona, Peter H Schafer, Rajesh Chopra
Journal: Blood (2012)
Tracking the Extramedullary PML-RARα-Positive Cell Reservoirs in a Preclinical Model of APL: Biomarker of Long-Term Drug Efficacy
Authors: Katerina Pokorna, Carole Le Pogam, Martine Chopin, Bruno Cassinat, Pierre Fenaux, Christine Chomienne, Rose Ann Padua, Marika Pla
Journal: Blood (2012)
Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma.
Authors: Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Nicole Grant, Seth Steinberg, Mark Raffeld, Bruce Chabner, Michael Grossbard, Elaine Jaffe, Louis Staudt, John Janik
Journal: Blood (2004)
Continuous Exposure to Bendamustine (BDM) Results in Stable Upregulation of CD30 and Increased Sensitivity to Brentuximab Vedotin (BV) in Tumor Cells of Hodgkin Lymphoma (HL)
Authors: Rosaria De Filippi, Michele Cillo, Stefania Crisci, Sara Mele, Serena Zanotta, Angela De Monaco, Domenico Galati, Giancarla Iaccarino, Raffaele Di Francia, Emanuela Morelli, Gianpaolo Marcacci, Cristina Becchimanzi, Attilio Guarini, Ferdinando Frigeri, Gaetano Corazzelli, Antonello Pinto
Journal: Blood (2015)
The Impact of Allogeneic Stem Cell Transplantation As Part of First Line Treatment on Outcome of Patients with Multiple Myeloma Depends on the Method of Analysis
Authors: Raynier Devillier, Jurjen Versluis, Bronno Van der Holt, Marie Jose Kersten, Reinier Raymakers, Sonja Zweegman, Gerard M.J. Bos, Nicolaas PM Schaap, Annemiek Broyl, Pieter Sonneveld, Henk Lokhorst, Jan J. Cornelissen
Journal: Blood (2014)
Autoimmune or Chronic Infectious Disease in B-CLL at Diagnosis: Association with Unmutated VH Gene Status and Unfavorable Cytogenetics.
Authors: Katrina Vanura, Trang Le, Harald Esterbauer, Florentin Spaeth, Edith Porpaczy, Medhat Shehata, Karin Eigenberger, Alexander Hauswirth, Cathrin Scrabs, Elisabeth Kroemer, Ilse Schwarzinger, Berthold Streubel, Christa Fonatsch, Stephan Stilgenbauer, Alexander Gaiger, Ulrich Jaeger
Journal: Blood (2007)
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression
Authors: Valentina Giudice, Monia Rocco, Luca Pezzullo, Giancarlo Villani, Rosa Rosamilio, Luigi Marino, Silvana Annunziata, Raffaele Fontana, Idalucia Ferrara, Bianca Serio, Carmine Selleri
Journal: Blood (2016)
Cerebellar Intracerebral Hemorrhage
Authors: J. Claude Hemphill, Sepideh Amin-Hanjani
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal